category,datetime,headline,id,image,related,source,summary,url
company,1768513200,Amgen’s Weight-Loss Drug Shows Promise With Less Frequent Dosing,138137483,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,AMGN,Yahoo,"Amgen reported early Phase 2 data suggesting patients kept weight off with less frequent dosing, a potential differentiator from Eli Lilly and Novo Nordisk.",https://finnhub.io/api/news?id=2e96d36c64fc6d1861ba3195c8158701ef3c48a440537ddb742cbdee3f0525dd
company,1768503121,Amgen Inc. (AMGN): A Bull Case Theory,138126500,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,AMGN,Yahoo,"We came across a bullish thesis on Amgen Inc. on Disruptive analytics’s Substack by Magnus Ofstad. In this article, we will summarize the bulls’ thesis on AMGN. Amgen Inc.’s share was trading at $325.54 as of January 12th. AMGN’s trailing and forward P/E were 25.18 and 14.79 respectively according to Yahoo Finance. Amgen Inc. discovers, develops, manufactures, and […]",https://finnhub.io/api/news?id=3c61b6e1edca0646e36140886e9bc4f17e418b5529e6d0ae0c096200836b10b5
